Hormone Therapy
Primary ovarian insufficiency, reproductive cancers may be linked across generations
BOSTON — People with primary ovarian insufficiency have higher risk for breast cancer and borderline increased risk for ovarian cancer compared with the general population, and risks for some cancers extend to their relatives, data show.
Menopause may unmask vulnerability to Alzheimer’s disease, other dementias
BOSTON — Menopause is a neurologic transition involving metabolic and immune systems of the brain, and timely estrogen therapy could reduce the risk for developing dementias and other neurogenerative diseases, according to a speaker.
Q&A: At 20 years, WHI emphasizes personalized postmenopausal care, shared decision-making
Results of Women’s Health Initiative trials highlight the importance of personalized health care in combination with shared decision-making for postmenopausal women, according to a review published in JAMA.
Q&A: Stigma, fear drive spread of menopause misinformation on social media
SAN FRANCISCO — Health care providers must combat menopause misinformation on social media by providing evidence-based information at visits and on online platforms, according to presenters at the ACOG Annual Clinical & Scientific Meeting.
Type of menopausal hormone therapy may influence cancer risk
CHICAGO — Cancer risk among women varied based on the type of menopausal hormone therapy they used, according to randomized study results scheduled for presentation at ASCO Annual Meeting.
Most transgender teens reach adult height close to their sex assigned at birth after HT
Most transgender adolescents receiving a gonadotropin-releasing hormone agonist combined with gender-confirming hormone therapy grow to an adult height close to the reference height for their sex assigned at birth, according to study data.
OASIS: Fewer, less severe hot flashes observed with nonhormonal elinzanetant
SAN FRANCISCO — In two phase 3 trials, the nonhormonal investigational agent elinzanetant was associated with decreased frequency and severity of menopausal vasomotor symptoms over 12 weeks with a favorable safety profile.
Black, Asian patients with breast cancer more likely to decline certain treatments
Racial and ethnic minorities with breast cancer had a higher likelihood of declining various treatment options than white patients in the past 2 decades, results from a retrospective study published in JAMA Network Open showed.
Premature surgical menopause tied to musculoskeletal discomfort, sarcopenia risk
Premature surgical menopause may increase the likelihood of musculoskeletal discomfort and sarcopenia, highlighting the potential importance of hormones in postmenopausal musculoskeletal health, researchers reported in Menopause.
Top in women’s health: Hormone therapy after age 65; OTC birth control pill hits shelves
The use of hormone therapy among women aged 65 years or older was associated with reductions in the risks for mortality, certain cancers and cardiovascular outcomes that varied by hormone therapy type, a recent study found.